This company has shut down. Ribon Therapeutics is no longer operating — its last tracked round was a Venture - Series Unknown in 2022.
Explore the Startup GraveyardRibon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Ribon Therapeutics has raised $25.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.
Ribon Therapeutics's investors include AbbVie, U.S. Venture Partners, The Column Group, Johnson & Johnson Innovation, Google Ventures.
Ribon Therapeutics is headquartered in Cambridge, United States.
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Ribon Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ribon Therapeutics — Funding & Investors." VCBacked, December 22, 2022, https://www.vcbacked.co/company/ribon-therapeutics. Accessed August 13, 2026.
VCBacked. (2022). Ribon Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/ribon-therapeutics
{{cite web |title=Ribon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ribon-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated